{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T13:51:54Z","timestamp":1793886714961,"version":"4.8.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod Biol Endocrinol"],"DOI":"10.1186\/s12958-025-01447-3","type":"journal-article","created":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T07:34:30Z","timestamp":1753515270000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Effects of combined metformin and semaglutide therapy on body weight, metabolic parameters, and reproductive outcomes in overweight\/obese women with polycystic ovary syndrome: a prospective, randomized, controlled, open-label clinical trial"],"prefix":"10.1186","volume":"23","author":[{"given":"Haiyan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoran","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongfang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hu","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,26]]},"reference":[{"issue":"1","key":"1447_CR1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41572-024-00511-3","volume":"10","author":"E Stener-Victorin","year":"2024","unstructured":"Stener-Victorin E, Teede H, Norman RJ, Legro R, Goodarzi MO, Dokras A, Laven J, Hoeger K, Piltonen TT. Polycystic ovary syndrome. Nat Rev Dis Primers. 2024;10(1):27.","journal-title":"NAT REV DIS PRIMERS"},{"key":"1447_CR2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1741-7015-8-41","volume":"8","author":"H Teede","year":"2010","unstructured":"Teede H, Deeks A, Moran L. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med. 2010;8:41.","journal-title":"BMC MED"},{"issue":"8","key":"1447_CR3","doi-asserted-by":"publisher","first-page":"e2695","DOI":"10.1210\/clinem\/dgaa285","volume":"105","author":"H Cena","year":"2020","unstructured":"Cena H, Chiovato L, Nappi RE. Obesity, polycystic ovary syndrome, and infertility: A new avenue for GLP-1 receptor agonists. J Clin Endocr Metab. 2020;105(8):e2695\u2013709.","journal-title":"J CLIN ENDOCR METAB"},{"issue":"6","key":"1447_CR4","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1093\/humupd\/dms030","volume":"18","author":"SS Lim","year":"2012","unstructured":"Lim SS, Davies MJ, Norman RJ, Moran LJ. Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2012;18(6):618\u201337.","journal-title":"HUM REPROD UPDATE"},{"issue":"7","key":"1447_CR5","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1016\/j.fertnstert.2010.02.047","volume":"94","author":"L Pelletier","year":"2010","unstructured":"Pelletier L, Baillargeon J. Clinically significant and sustained weight loss is achievable in obese women with polycystic ovary syndrome followed in a regular medical practice. Fertil Steril. 2010;94(7):2665\u20139.","journal-title":"FERTIL STERIL"},{"issue":"1","key":"1447_CR6","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ejogrb.2004.06.043","volume":"119","author":"A Tolino","year":"2005","unstructured":"Tolino A, Gambardella V, Caccavale C, D\u2019Ettore A, Giannotti F, D\u2019Anto V, De Falco CL. Evaluation of ovarian functionality after a dietary treatment in obese women with polycystic ovary syndrome. Eur J Obstet Gyn R B. 2005;119(1):87\u201393.","journal-title":"EUR J OBSTET GYN R B"},{"key":"1447_CR7","doi-asserted-by":"publisher","first-page":"495","DOI":"10.2147\/DMSO.S85134","volume":"8","author":"EA Nikokavoura","year":"2015","unstructured":"Nikokavoura EA, Johnston KL, Broom J, Wrieden WL, Rolland C. Weight loss for women with and without polycystic ovary syndrome following a very low-calorie diet in a community-based setting with trained facilitators for 12 weeks. Diabet Metab Synd OB. 2015;8:495\u2013503.","journal-title":"DIABET METAB SYND OB"},{"issue":"3","key":"1447_CR8","first-page":"CD007506","volume":"3","author":"SS Lim","year":"2019","unstructured":"Lim SS, Hutchison SK, Van Ryswyk E, Norman RJ, Teede HJ, Moran LJ. Lifestyle changes in women with polycystic ovary syndrome. Cochrane DB Syst Rev. 2019;3(3):CD007506.","journal-title":"COCHRANE DB SYST REV"},{"issue":"11","key":"1447_CR9","first-page":"CD003053","volume":"11","author":"LC Morley","year":"2017","unstructured":"Morley LC, Tang T, Yasmin E, Norman RJ, Balen AH. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane DB Syst Rev. 2017;11(11):CD003053.","journal-title":"COCHRANE DB SYST REV"},{"issue":"5","key":"1447_CR10","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1210\/jc.2011-3061","volume":"97","author":"L Morin-Papunen","year":"2012","unstructured":"Morin-Papunen L, Rantala AS, Unkila-Kallio L, Tiitinen A, Hippelainen M, Perheentupa A, Tinkanen H, Bloigu R, Puukka K, Ruokonen A, et al. Metformin improves pregnancy and live-birth rates in women with polycystic ovary syndrome (PCOS): a multicenter, double-blind, placebo-controlled randomized trial. J Clin Endocr Metab. 2012;97(5):1492\u2013500.","journal-title":"J CLIN ENDOCR METAB"},{"issue":"1","key":"1447_CR11","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.rbmo.2017.03.023","volume":"35","author":"M Nylander","year":"2017","unstructured":"Nylander M, Frossing S, Clausen HV, Kistorp C, Faber J, Skouby SO. Effects of liraglutide on ovarian dysfunction in polycystic ovary syndrome: a randomized clinical trial. Reprod Biomed Online. 2017;35(1):121\u20137.","journal-title":"REPROD BIOMED ONLINE"},{"key":"1447_CR12","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3389\/fendo.2014.00140","volume":"5","author":"CB Rasmussen","year":"2014","unstructured":"Rasmussen CB, Lindenberg S. The effect of liraglutide on weight loss in women with polycystic ovary syndrome: an observational study. Front Endocrinol. 2014;5:140.","journal-title":"FRONT ENDOCRINOL"},{"key":"1447_CR13","doi-asserted-by":"crossref","unstructured":"Bednarz K, Kowalczyk K, Cwynar M, Czapla D, Czarkowski W, Kmita D, Nowak A, Madej P. The role of Glp-1 receptor agonists in insulin resistance with concomitant obesity treatment in polycystic ovary syndrome. Int J Mol Sci 2022;23(8).","DOI":"10.3390\/ijms23084334"},{"key":"1447_CR14","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.metabol.2018.11.002","volume":"92","author":"CJ Glueck","year":"2019","unstructured":"Glueck CJ, Goldenberg N. Characteristics of obesity in polycystic ovary syndrome: etiology, treatment, and genetics. Metabolism. 2019;92:108\u201320.","journal-title":"METABOLISM"},{"issue":"7","key":"1447_CR15","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.1210\/jc.2008-0115","volume":"93","author":"K Elkind-Hirsch","year":"2008","unstructured":"Elkind-Hirsch K, Marrioneaux O, Bhushan M, Vernor D, Bhushan R. Comparison of single and combined treatment with exenatide and Metformin on menstrual Cyclicity in overweight women with polycystic ovary syndrome. J Clin Endocr Metab. 2008;93(7):2670\u20138.","journal-title":"J CLIN ENDOCR METAB"},{"issue":"3","key":"1447_CR16","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1111\/dom.15386","volume":"26","author":"W Qin","year":"2024","unstructured":"Qin W, Yang J, Deng C, Ruan Q, Duan K. Efficacy and safety of semaglutide 2.4\u00a0mg for weight loss in overweight or obese adults without diabetes: an updatedsystematic review and meta-analysis including the 2-year STEP 5 trial. Diabetes Obes Metab. 2024;26(3):911\u201323.","journal-title":"DIABETES OBES METAB"},{"key":"1447_CR17","doi-asserted-by":"crossref","unstructured":"Carmina E, Longo RA. Semaglutide treatment of excessive body weight in obese PCOS patients unresponsive to lifestyle programs. J Clin Med 2023;12(18).","DOI":"10.3390\/jcm12185921"},{"key":"1447_CR18","unstructured":"Guidelines for the Prevention and Control of Overweight and Obesity in Chinese Adults (2021 Revision). People\u2019s Medical Publishing House. 2021;14."},{"issue":"8","key":"1447_CR19","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1056\/NEJMoa066254","volume":"357","author":"L Sjostrom","year":"2007","unstructured":"Sjostrom L, Narbro K, Sjostrom CD, Karason K, Larsson B, Wedel H, Lystig T, Sullivan M, Bouchard C, Carlsson B, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. New Engl J Med. 2007;357(8):741\u201352.","journal-title":"NEW ENGL J MED"},{"issue":"6","key":"1447_CR20","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1210\/endrev\/bnac001","volume":"43","author":"M Dapas","year":"2022","unstructured":"Dapas M, Dunaif A. Deconstructing a syndrome: genomic insights into PCOS causal mechanisms and classification. Endocr Rev. 2022;43(6):927\u201365.","journal-title":"ENDOCR REV"},{"issue":"6","key":"1447_CR21","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.ajog.2010.06.043","volume":"203","author":"ES Jungheim","year":"2010","unstructured":"Jungheim ES, Moley KH. Current knowledge of obesity\u2019s effects in the pre- and periconceptional periods and avenues for future research. Am J Obstet Gynecol. 2010;203(6):525\u201330.","journal-title":"AM J OBSTET GYNECOL"},{"issue":"2","key":"1447_CR22","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.mce.2009.09.026","volume":"316","author":"D Rachon","year":"2010","unstructured":"Rachon D, Teede H. Ovarian function and obesity\u2013interrelationship, impact on women\u2019s reproductive lifespan and treatment options. Mol Cell Endocrinol. 2010;316(2):172\u20139.","journal-title":"MOL CELL ENDOCRINOL"},{"key":"1447_CR23","doi-asserted-by":"crossref","unstructured":"Goodman NF, Cobin RH, Futterweit W, Glueck JS, Legro RS, Carmina E, American association of clinical endocrinologists, american college of endocrinology, and androgen excess and pcos society disease state clinical review: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome. - part 2. Endocr Pract 2015;21(12):1415\u20131426.","DOI":"10.4158\/EP15748.DSCPT2"},{"issue":"20","key":"1447_CR24","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1001\/jama.2023.19897","volume":"330","author":"A Elmaleh-Sachs","year":"2023","unstructured":"Elmaleh-Sachs A, Schwartz JL, Bramante CT, Nicklas JM, Gudzune KA, Jay M. Obesity management in adults: A review. JAMA-J Am Med Assoc. 2023;330(20):2000\u201315.","journal-title":"JAMA-J AM MED ASSOC"},{"issue":"3","key":"1447_CR25","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.ajcnut.2023.04.017","volume":"118","author":"Y Liu","year":"2023","unstructured":"Liu Y, Ruan B, Jiang H, Le S, Liu Y, Ao X, Huang Y, Shi X, Xue R, Fu X, et al. The Weight-loss effect of GLP-1RAs Glucagon-Like Peptide-1 receptor agonists in Non-diabetic individuals with overweight or obesity: A systematic review with Meta-Analysis and trial sequential analysis of randomized controlled trials. Am J Clin Nutr. 2023;118(3):614\u201326.","journal-title":"AM J CLIN NUTR"},{"issue":"3","key":"1447_CR26","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3109\/07435800.2014.966385","volume":"40","author":"M Jensterle","year":"2015","unstructured":"Jensterle M, Kocjan T, Kravos NA, Pfeifer M, Janez A. Short-term intervention with liraglutide improved eating behavior in obese women with polycystic ovary syndrome. Endocr Res. 2015;40(3):133\u20138.","journal-title":"ENDOCR RES"},{"issue":"8","key":"1447_CR27","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1089\/met.2019.0019","volume":"17","author":"J Long","year":"2019","unstructured":"Long J, Li L, Wang F, Yang G, Cheng W, Wei J, Chen M, Liu D. Screening for a simple and effective Indicator of insulin resistance in Chinese Reproductive-Aged women, with the insulin clamp technique as a reference. Metab Syndr Relat D. 2019;17(8):423\u20139.","journal-title":"METAB SYNDR RELAT D"},{"issue":"9","key":"1447_CR28","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1111\/dom.12932","volume":"19","author":"J Blundell","year":"2017","unstructured":"Blundell J, Finlayson G, Axelsen M, Flint A, Gibbons C, Kvist T, Hjerpsted JB. Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity. Diabetes Obes Metab. 2017;19(9):1242\u201351.","journal-title":"DIABETES OBES METAB"},{"key":"1447_CR29","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1017\/S1462399408000598","volume":"10","author":"E Diamanti-Kandarakis","year":"2008","unstructured":"Diamanti-Kandarakis E. Polycystic ovarian syndrome: pathophysiology, molecular aspects and clinical implications. Expert Rev Mol Med. 2008;10:e3.","journal-title":"EXPERT REV MOL MED"},{"key":"1447_CR30","doi-asserted-by":"publisher","first-page":"945609","DOI":"10.3389\/fendo.2022.945609","volume":"13","author":"C Xing","year":"2022","unstructured":"Xing C, Zhao H, Zhang J, He B. Effect of Metformin versus Metformin plus liraglutide on gonadal and metabolic profiles in overweight patients with polycystic ovary syndrome. Front Endocrinol. 2022;13:945609.","journal-title":"FRONT ENDOCRINOL"},{"key":"1447_CR31","doi-asserted-by":"publisher","first-page":"3925","DOI":"10.2147\/DDDT.S484531","volume":"18","author":"M Liu","year":"2024","unstructured":"Liu M, Guo S, Li X, Tian Y, Yu Y, Tang L, Sun Q, Zhang T, Fan M, Zhang L, et al. Semaglutide alleviates ovary inflammation via the AMPK\/SIRT1\/NF\u2013kappaB signaling pathway in polycystic ovary syndrome mice. Drug Des Devel Ther. 2024;18:3925\u201338.","journal-title":"Drug Des Devel Ther"},{"issue":"5","key":"1447_CR32","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1530\/rep.0.1240601","volume":"124","author":"ALL Durlinger","year":"2002","unstructured":"Durlinger ALL, Visser JA, Themmen APN. Regulation of ovarian function: the role of anti-Mullerian hormone. Reproduction. 2002;124(5):601\u20139.","journal-title":"Reproduction"},{"issue":"9","key":"1447_CR33","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1093\/humrep\/dead156","volume":"38","author":"HJ Teede","year":"2023","unstructured":"Teede HJ, Tay CT, Laven J, Dokras A, Moran LJ, Piltonen TT, Costello MF, Boivin J, Redman LM, Boyle JA, et al. Recommendations from the 2023 international Evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod. 2023;38(9):1655\u201379.","journal-title":"HUM REPROD"},{"issue":"1","key":"1447_CR34","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.rbmo.2016.04.007","volume":"33","author":"D Garg","year":"2016","unstructured":"Garg D, Tal R. The role of AMH in the pathophysiology of polycystic ovarian syndrome. Reprod Biomed Online. 2016;33(1):15\u201328.","journal-title":"REPROD BIOMED ONLINE"},{"issue":"4","key":"1447_CR35","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.fertnstert.2021.05.094","volume":"116","author":"A De Dietz","year":"2021","unstructured":"De Dietz A, Hund M, Buck K, Meun C, Sillman J, Laven JSE. Antim\u00fcllerian hormone to determine polycystic ovarian morphology. Fertil Steril. 2021;116(4):1149\u201357.","journal-title":"FERTIL STERIL"},{"issue":"3","key":"1447_CR36","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3109\/09513590.2014.975686","volume":"31","author":"B Artunc-Ulkumen","year":"2015","unstructured":"Artunc-Ulkumen B, Pala HG, Pala EE, Yavasoglu A, Yigitturk G, Erbas O. Exenatide improves ovarian and endometrial injury and preserves ovarian reserve in Streptozocin induced diabetic rats. Gynecol Endocrinol. 2015;31(3):196\u2013201.","journal-title":"GYNECOL ENDOCRINOL"},{"issue":"6","key":"1447_CR37","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1111\/cen.13454","volume":"87","author":"X Liu","year":"2017","unstructured":"Liu X, Zhang Y, Zheng S, Lin R, Xie Y, Chen H, Zheng Y, Liu E, Chen L, Yan J, et al. Efficacy of exenatide on weight loss, metabolic parameters and pregnancy in overweight\/obese polycystic ovary syndrome. Clin Endocrinol. 2017;87(6):767\u201374.","journal-title":"CLIN ENDOCRINOL"},{"issue":"1","key":"1447_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1530\/EJE-18-0175","volume":"179","author":"V Salamun","year":"2018","unstructured":"Salamun V, Jensterle M, Janez A, Vrtacnik Bokal E. Liraglutide increases IVF pregnancy rates in obese PCOS women with poor response to first-line reproductive treatments: a pilot randomized study. Eur J Endocrinol. 2018;179(1):1\u201311.","journal-title":"EUR J ENDOCRINOL"},{"issue":"6","key":"1447_CR39","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1210\/jcem.86.6.7580","volume":"86","author":"CC Kelly","year":"2001","unstructured":"Kelly CC, Lyall H, Petrie JR, Gould GW, Connell JM, Sattar N. Low grade chronic inflammation in women with polycystic ovarian syndrome. J Clin Endocr Metab. 2001;86(6):2453\u20135.","journal-title":"J CLIN ENDOCR METAB"},{"issue":"10","key":"1447_CR40","doi-asserted-by":"publisher","first-page":"4649","DOI":"10.1210\/jc.2002-021688","volume":"88","author":"L Morin-Papunen","year":"2003","unstructured":"Morin-Papunen L, Rautio K, Ruokonen A, Hedberg P, Puukka M, Tapanainen JS. Metformin reduces serum C-reactive protein levels in women with polycystic ovary syndrome. J Clin Endocr Metab. 2003;88(10):4649\u201354.","journal-title":"J CLIN ENDOCR METAB"}],"container-title":["Reproductive Biology and Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-025-01447-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12958-025-01447-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-025-01447-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T01:27:44Z","timestamp":1757294864000},"score":1,"resource":{"primary":{"URL":"https:\/\/rbej.biomedcentral.com\/articles\/10.1186\/s12958-025-01447-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,26]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1447"],"URL":"https:\/\/doi.org\/10.1186\/s12958-025-01447-3","relation":{},"ISSN":["1477-7827"],"issn-type":[{"value":"1477-7827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,26]]},"assertion":[{"value":"17 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the hospital\u2019s ethics committee of the Second Affiliated Hospital of Chongqing Medical University (Approval No. 2024204) and registered on Chinese Clinical Trial Registry (ChiCTR2400090908) in October 15, 2024. All participants received written and oral information and signed informed consent before any examination.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Any opinions or recommendations discussed are solely those of the author(s).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimers"}},{"value":"Chongqing medical scientific research project (Joint project of Chongqing Health Commission and Science and Technology Bureau) (2025MSXM106), the First batch of key Disciplines on Public Health in Chongqing, the National Natural Science Foundation of China (Grants 81501199 to C.W.), the Natural Science Foundation Project of Chongqing CSTC (cstc2017jcyjAX0016 to C.W. and CSTB2022NSCQ-MSX1008 to C.W.).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Source(s)of support"}},{"value":"The authors declare no competing interests.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"108"}}